Ascorbic Acid Inj. Solution recall — Class I (D-0040-2025) · pharmaranks
Class ITerminated
Ascorbic Acid Inj. Solution recall
FDA recall D-0040-2025 · initiated Sep 30, 2024
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Presence of Particulate Matter: Presence of glass particulates.
Details
Product
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Recalling company
Staska Pharmaceuticals, Inc.
Classification
Class I
Status
Terminated
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Sep 30, 2024
FDA report date
Nov 13, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.